Attacking Alzheimer's
- 00:04:30
- CNBC
Previous Page
Next Page
Attacking Alzheimer's
Discussing Wyeth-Elan's drug to treat Alzheimer's diesease and an outlook on the company, with Kelly Martin, Elan CEO
CNBC | July 30, 2008
Discussing Wyeth-Elan's drug to treat Alzheimer's diesease and an outlook on the company, with Kelly Martin, Elan CEO
CNBC | July 30, 2008
